Concepedia

Yongli Zhao

YZ

Statistics

Publications

13

Citations

360

H-Index

11

Active since

2013

Affiliations

First Affiliated Hospital of Xinxiang Medical University(Current)

Henan Medical University

Qingdao University

Qingdao Municipal Hospital

Shuozhou Central Hospital

Yongli Zhao is an author at First Affiliated Hospital of Xinxiang Medical University specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2013–2024

13

Publications

13

Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer.

Guan-Fang Ping, Wancheng Xiong, Lanfang Zhang et al. · PubMed · 2018 · 86 citations

, , +17

Suppression of microRNA‐144‐3p attenuates oxygen–glucose deprivation/reoxygenation‐induced neuronal injury by promoting Brg1/Nrf2/ARE signaling

Yanru Li, Yongli Zhao, Ming-Kun Cheng et al. · Journal of Biochemical and Molecular Toxicology · 2018 · 52 citations

, , +17

MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.

Yongli Zhao, LI Fen-bao, Xizhong Zhang et al. · PubMed · 2015 · 48 citations

, , +17

Apatinib suppresses the migration, invasion and angiogenesis of hepatocellular carcinoma cells by blocking VEGF and PI3K/AKT signaling pathways

Jifu Song, Zhibin Guan, Chao Song et al. · Molecular Medicine Reports · 2021 · 30 citations · Full text

, , +17

MicroRNA-154 Inhibits the Growth and Invasion of Gastric Cancer Cells by Targeting DIXDC1/WNT Signaling

Jifu Song, Zhibin Guan, Maojiang Li et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2017 · 22 citations · Full text

, , +17

1–5 of 13